Frequency Therapeutics logo — company profile

Frequency Therapeutics

Founded 2015 United States Lexington, United States 15 employees Post-IPO Equity Total: $118.30M Biotechnology, Health Care

General Information

Company Name Frequency Therapeutics
Founded Year 2015
Location United States Lexington, United States
Founders / Decision Makers
Team member Team member
Employees 15
Industries Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Frequency Therapeutics. To contact Frequency Therapeutics, visit frequencytx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Frequency Therapeutics compare?

A PDF of Frequency Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Frequency Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Frequency Therapeutics

Frequency Therapeutics is a biotechnology company founded in 2015 and headquartered in the United States. It is pioneering a new category in regenerative medicine by developing therapeutics that activate a person’s innate regenerative potential within the body. The company's progenitor cell activation platform aims to restore human function by activating oligodendrocyte precursor cells, with the specific goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis. The company received a Post-IPO Equity investment on 15 August 2022, with Taiwania Capital Management Corporation being the investor. This investment demonstrates confidence in Frequency Therapeutics' innovative approach to regenerative medicine and its potential to bring about significant advancements in the field. With its focus on leveraging the body's own regenerative abilities, Frequency Therapeutics is positioned at the forefront of cutting-edge biotechnology, offering promising solutions for individuals with neurodegenerative conditions.

Business keywords: Regenerative Medicine, Progenitor Cell Activation, Therapeutics Development, Oligodendrocyte Precursor Cells, Remyelination, Multiple Sclerosis, Medical Research, Innovation, Stem Cell Activation, Regenerative Potential, Function Restoration, Preclinical Program, Drug Development

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed 1
Taiwania Capital Management Corporation
15 Aug 2022
Post IPO Equity $42.30M 7
Alexandria Venture Investments, Driehaus Capital Management +5
17 Jul 2020
Series C Undisclosed 9
Axil Capital, CoBro Ventures +7
23 Jul 2019
Series B $42.00M 6
Korea Investment Partners, Emigrant Capital +4
07 Jan 2019
Grant $2.00M 1
U.S. Department of Defense
30 May 2018
Grant Undisclosed 1
JDRF (The Juvenile Diabetes Research Foundation)
22 Feb 2018
Series B Undisclosed 1
Yonjin Venture
07 Jul 2017
Series A $32.00M 7
Korea Investment Partners, Emigrant Capital +5
11 Apr 2017

Frequency Therapeutics Alternatives & Competitors

View All Alternatives
Frequency Therapeutics vs

BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenera...

Post-IPO Equity
36 employees
Biotechnology, Health Care
Frequency Therapeutics vs

Developing Cell Therapies for Degenerative Disease.

Series C
15 employees
Biotechnology, Health Care
Frequency Therapeutics vs

AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targetin...

Post-IPO Equity
12 employees
Biotechnology, Health Care

FAQ About Frequency Therapeutics

Frequency Therapeutics is pioneering a new category in regenerative medicine. Frequency’s progenitor cell activation platform aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body. The Company’s lead preclinical program is de...
Frequency Therapeutics was founded in 2015.
Frequency Therapeutics is headquartered in Lexington, United States.
Frequency Therapeutics operates in Biotechnology and Health Care. Its work centres on Regenerative Medicine, Progenitor Cell Activation, Therapeutics Development and Oligodendrocyte Precursor Cells.
Frequency Therapeutics has approximately 15 employees.
Frequency Therapeutics has completed 8 funding rounds, raising a total of $118.30M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Frequency Therapeutics include Brainstorm Cell Therapeutics, Help Therapeutics, AgeX Therapeutics, Inc. , Cellf BIO, Inc., ViaCyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Frequency Therapeutics and Brainstorm Cell Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Frequency Therapeutics, https://bouncewatch.com/company/frequency-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes